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Phage therapy is a promising option for fighting against staphylococcal infections. Two lytic phages, vB_SauM_phiIPLA-RODI
(phiIPLA-RODI) and vB_SepM_phiIPLA-C1C (phiIPLA-C1C), belonging to theMyoviridae family and exhibiting wide host
ranges, were characterized in this study. The complete genome sequences comprised 142,348 bp and 140,961 bp and contained
213 and 203 open reading frames, respectively. The gene organization was typical of Spounavirinaemembers, with long direct
terminal repeats (LTRs), genes grouped into modules not clearly separated from each other, and several group I introns. In addi-
tion, four genes encoding tRNAs were identified in phiIPLA-RODI. Comparative DNA sequence analysis showed high similari-
ties with two phages, GH15 and 676Z, belonging to the Twort-like virus genus (nucleotide identities of>84%); for phiIPLA-
C1C, a high similarity with phage phiIBB-SEP1 was observed (identity of 80%). Challenge assays of phages phiIPLA-RODI and
phiIPLA-C1C against planktonic staphylococcal cells confirmed their lytic ability, as they were able to remove 5 log units in 8 h.
Exposure of biofilms to phages phiIPLA-RODI and phiIPLA-C1C reduced the amount of adhered bacteria to about 2 log units in
both monospecies and dual-species biofilms, but phiIPLA-RODI turned out to be as effective as the mixture of both phages.
Moreover, the frequencies of bacteriophage-insensitive mutants (BIMs) of Staphylococcus aureus and S. epidermidis with resis-
tance to phiIPLA-RODI and phiIPLA-C1C were low, at 4.05 107 2.34 109 and 1.1 107 2.08 109, respectively.
Overall, a generally reduced fitness in the absence of phages was observed for BIMs, which showed a restored phage-sensitive
phenotype in a few generations. These results confirm that lytic bacteriophages can be efficient biofilm-disrupting agents, sup-
porting their potential as antimicrobials against staphylococcal infections.
Two staphylococcal species, Staphylococcus aureus and Staphy-lococcus epidermidis, are the main causes of nosocomial infec-
tions due to their ability to adhere to, colonize, and develop biofilms
in medical devices and human organs (1). Staphylococcal biofilms
are complex structures in which bacterial cells are surrounded by an
extracellular material (polysaccharides, teichoic acids, proteins, and
extracellular DNA) which confers protection against antibacterial
drugs and thehost immune system. In addition, growthof bacteria in
abiofilmfacilitates thedevelopmentof antibiotic-resistantorganisms
(2). S. epidermidis is one of the most abundant species in the hu-
man skin microbiota, from which it easily reaches catheters, heart
valves, and contact lenses. Despite being regarded as an innocuous
bacterium, it is now accepted as an opportunistic pathogen and
one of the most common causes of bacteremia in immunocom-
promised patients (3), preterm infants (4), and biofilm-related
infections (5). In addition, resistance to methicillin due to the
presence of themecA gene is widely spread in hospital isolates (6).
Similarly, virulence in S. aureus is mainly due to its ability to ad-
here to and proliferate on biotic and abiotic surfaces (7). In hos-
pital settings, S. aureus infections affecting internal organs and
implanted medical devices have become difficult to eradicate.
Moreover, methicillin-resistant S. aureus (MRSA) strains are of-
ten prevalent in hospitals and have recently spread to nonrelated
environments, affecting people without exposure to the health
care environment (8). MRSA strains have also been isolated from
foods of animal origin (9) and from livestock (10).
Phage therapy exploits the ability of phages to infect and kill bac-
teria in the treatment of infectious diseases. This represents a poten-
tial alternative toantibiotics tofight againstmultiresistantpathogenic
bacteria or superbugs (11). Indeed, human trials with phages against
a number of infections have confirmed their safety and shown that
phage therapy canprovide good results for untreatable chronic infec-
tions (12,13).Specifically, recent results showedtheefficacyofphages
in animal models, such as S. aureus septicemia in mice (14) and in
silkworms (15). The safety and efficacy of phage products for re-
moval of this bacterium in a sinusitis sheep model have also been
proven (16). Other applications of phages against S. aureus en-
compass improvements in wound healing developed on diabetic
patients (17, 18) and the treatment of chronic wounds (19). Pre-
vious results also showed the ability of phages to remove biofilms
formed by staphylococcal species (20–22).
In this study, we report a complete morphological and genetic
characterization of two new phages infecting staphylococcal species,
named vB_SauM_phiIPLA-RODI (phiIPLA-RODI) and vB_SepM_
phiIPLA-C1C(phiIPLA-C1C) following thenomenclatureproposed
by Kropinski et al. (23). The lytic abilities of these phages, including
host range and biofilm removal, were analyzed. Furthermore, the
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frequency of bacteriophage-insensitive mutants (BIMs) of plank-
tonic cells was calculated for both phages, and a preliminary charac-
terization of these resistant bacteria is also presented.
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and growth conditions. Forty-four
different staphylococcal species and one Macrococcus caseolyticus strain
were used in this study (Table 1). All the bacteria were isolated in Baird-
Parker (BP) agar and were routinely cultured in tryptic soy broth (TSB;
Scharlau, Barcelona, Spain) at 37°C with shaking or on TSB plates con-
taining 2% (wt/vol) bacteriological agar (TSA).
To select S. aureus IPLA16 colonies resistant to rifampin (S. aureus
IPLA16-rifR), 100-l aliquots of overnight cultures were plated onto TSA
plates supplemented with 100 g/ml of rifampin. Plates were incubated
for 16 h at 37°C. Single colonies were picked up and grown in fresh TSB at
37°C with shaking for further studies.
TABLE 1 Strains used in this study, with origins and phage sensitivities, expressed as efficiencies of plaque formation (EOP)
Species Strain Origin Reference
EOPa
phiIPLA-RODI phiIPLA-C1C
S. aureus IPLA-1 Dairy industry surfaces 66 1 —
IPLA-2 Dairy industry surfaces 66 0.98 0.03 —
IPLA-3 Dairy industry surfaces 66 0.87 0.06 —
IPLA-4 Dairy industry surfaces 66 1.03 0.04 —
IPLA-5 Dairy industry surfaces 66 0.91 0.01 —
IPLA-6 Meat industry surfaces 66 1.01 0.03 —
IPLA-7 Meat industry surfaces 66 0.99 0.03 —
IPLA-8 Meat industry surfaces 66 0.85 0.11 —
IPLA-9 Meat industry surfaces 66 0.92 0.23 —
IPLA-10 Meat industry surfaces 66 0.87 0.07 —
IPLA-11 Meat industry surfaces 66 0.89 0.06 0.09 0.01
IPLA-12 Meat industry surfaces 66 0.79 0.05 —
IPLA-13 Meat industry surfaces 66 1.02 0.03 —
IPLA-14 Meat industry surfaces 66 0.96 0.02 —
IPLA-15 Meat industry surfaces 66 1.02 0.03 —
IPLA-16 Meat industry surfaces 66 1.23 0.04 1.09 0.07
IPLA-17 Meat industry surfaces 66 1.06 0.01 —
IPLA-18 Meat industry surfaces 66 0.96 0.02 0.39 0.05
IPLA-19 Milk sample Unpublished data 1.12 0.03 —
15981 Clinical isolate 67 0.99 0.02 —
V329 Bovine subclinical mastitis 68 1.01 0.01 —
S. epidermidis F12 Women’s breast milk 69 — 1
B Women’s breast milk 69 0.19 0.01 0.78 0.01
DH3LIK Women’s breast milk 69 — 0.56 0.07
YLIC13 Women’s breast milk 69 — 0.77 0.06
Z2LDC14 Women’s breast milk 69 — 0.62 0.03
DG2ñ Women’s breast milk 69 — 0.88 0.06
ASLD1 Women’s breast milk 69 — 0.62 0.04
LO5081 Women’s breast milk 69 0.87 0.04 1.23 0.04
LX5RB4 Women’s breast milk 69 — 0.89 0.02
LO5RB1 Women’s breast milk 69 — 0.97 0.03
Staphylococcus haemolyticus ZL89-3 Women’s breast milk 70 0.91 0.03 —
ZL114-1 Women’s breast milk 70 0.87 0.02 —
Staphylococcus hominis ZL31-13 Women’s breast milk 70 0.77 0.05 —
ZL5-5 Women’s breast milk 70 0.68 0.01 —
Staphylococcus arlettae ZL114-5 Women’s breast milk 70 0.45 0.03 —
ZL98-5 Women’s breast milk 70 0.55 0.08 0.23 0.04
Staphylococcus lugdunensis ZL5-11 Women’s breast milk 70 0.69 0.04 0.56 0.05
Staphylococcus gallinarum ZL90-5 Women’s breast milk 70 0.71 0.06 0.68 0.01
Staphylococcus kloosii ZL74-2 Women’s breast milk 70 0.46 0.03 0.65 0.01
Staphylococcus pasteuri ZL16-6 Women’s breast milk 70 0.45 0.06 —
Staphylococcus xylosus ZL61-2 Women’s breast milk 70 0.65 0.02 0.56 0.01
Staphylococcus saprophyticus ZL112-15 Women’s breast milk 70 0.89 0.08 0.37 0.04
Staphylococcus sciuri IPLA301 Women’s breast milk 70 0.98 0.05 —
Macrococcus caseolyticus IPLA101 Dairy industry surface Unpublished data 0.65 0.03 0.06 0.03
a Data are means standard deviations calculated for three independent experiments. —, resistance to the phage.
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Bacteriophages phiIPLA-RODI and phiIPLA-C1C were propagated
on S. aureus IPLA1 and S. epidermidis F12, respectively, as previously
described (24).
Bacteriophage isolation and propagation. Bacteriophages were iso-
lated from a sewage treatment plant in Colunga, Asturias, Spain. For iso-
lation of staphylococcal phages, 1 liter of sewage was centrifuged twice at
13,600  g for 30 min, and the supernatant was filtered using 0.45-m
and 0.22-m cellulose acetate membrane filters sequentially (VWR,
Spain). Enrichment cultures were performed by mixing 20 ml of TSB
concentrated five times (5 TSB), 80 ml of filtered sewage, and 100 l of
overnight culture from one of four mixtures of S. aureus strains (mixture
1, S. aureus IPLA3, IPLA4, IPLA6, IPLA15, IPLA16, IPLA17, and IPLA18;
mixture 2, S. aureus IPLA5, IPLA8, and IPLA14; mixture 3, S. aureus
IPLA1, IPLA2, IPLA9, and IPLA10; and mixture 4, S. aureus IPLA7 and
IPLA13). After incubation for 16 h at 37°C, the samples were centrifuged
and filtered. A total of three enrichments were carried out to obtain higher
phage titrations. To assess the presence of phages, 5-l aliquots of the
supernatants from the different combinations were spotted onto bacterial
lawns of each of the S. aureus and S. epidermidis strains following the
double-layer technique (24). The presence of an inhibition halo was con-
sidered representative of phage sensitivity. Each inhibition halo was fur-
ther purified to isolate different phages. Two phages were reisolated,
propagated, and purified by use of a CsCl continuous-density gradient as
described previously (24). As host bacteria, S. aureus IPLA1 and S. epider-
midis F12 were used for the propagation and purification of phages
phiIPLA-RODI and phiIPLA-C1C, respectively.
Bacteriophage one-step growth curves, EOP, and stabilities at vari-
ous pHs and temperatures.One-step growth curveswere performedwith
phages phiIPLA-RODI and phiIPLA-C1C, using the sensitive strains S.
aureus IPLA16 and S. epidermidis LO5081, respectively, as previously de-
scribed (24). Bacteriophage host ranges were determined using phiIPLA-
RODI (109 PFU/ml) and phiIPLA-C1C (109 PFU/ml) in the drop test, and
titrations of the phages were further carried out with all sensitive strains to
differentiate between infection and lysis due to bacteriocins. The effi-
ciency of plaque formation (EOP) was determined by dividing the phage
titer on the test strain by the phage titer on the reference strain (S. aureus
IPLA1 for phage phiIPLA-RODI and S. epidermidis F12 for phage
phiIPLA-C1C).
The pH stability of the phage particles was tested by incubation in
Britton-Robinson pHuniversal buffer (150mMKCl, 10mMKH2PO4, 10
mM sodium citrate, 10 mM H3BO3, with adjustment of the pH in the
range from 3 to 11) for 3 h at room temperature. Similarly, the tempera-
ture stability was examined by incubating the phages in SM buffer (20
mg/liter Tris-HCl, 10 mg/liter MgSO4, 10 mg/liter CaCl2, 100 mg/liter
NaCl, pH 7.5) at different temperatures (ranging from 40°C to 90°C) for
30 min. Phage suspensions in SM buffer at 4°C were used as controls.
Bacterium-phage challenge testwith planktonic staphylococcal cul-
tures. Ten milliliters of TSB broth was inoculated with an overnight cul-
ture to an optical density at 600 nm (OD600) of 0.05 and then incubated at
37°C with shaking until reaching an OD600 of 0.1 (10
7 CFU/ml). A 100-
fold dilution of the culture was infected at a multiplicity of infection
(MOI) of 100 (107 PFU/ml). Infected cultures were incubated for 8 h at
37°C, and samples were taken at 2-h intervals. Phage and cell counts were
performed in triplicate.
Biofilm formation and biofilm-phage challenge test.Overnight cul-
tures of S. aureus IPLA16-rifR and S. epidermidis LO5081 were diluted to
106 CFU/ml in fresh TSB supplemented with 0.25% glucose. Aliquots of
200 l of each single culture or mixture of both strains (100 l of each
strain)were poured into a 96-microwell plate (ThermoScientific,Madrid,
Spain). Biofilms were grown for 24 h at 37°C. Wells were then washed
twicewith PBS (137mMNaCl, 2.7mMKCl, 10mMNa2HPO4, and 2mM
KH2PO4; pH7.4). To test biofilmdegradation by each phage, 100l of SM
buffer and 100 l of phiIPLA-RODI or phiIPLA-C1C were added to each
well (109 PFU/well). To test the combined effect of both phages, 200l of
the mixture of both phages was added to the well (109 PFU/well of each
phage). SM buffer was added for control purposes. The plates were incu-
bated for 4 h at 37°C, the supernatants were removed, and serial dilutions
were plated on TSA plates. The cells that were still bound after phage
treatment were collected by scratching twice with a sterile swab, sus-
pended in 9 ml of SM buffer, and vigorously vortexed for 1 min. Serial
dilutions were plated for bacterial counting. For mixed biofilms, S. epi-
dermidis counts were calculated as the differences between total staphylo-
coccal counts in TSA and the S. aureus IPLA16-rifR counts in TSA supple-
mented with 100 g/ml of rifampin.
Alternatively, the biomass adhered to thewell was observed by staining
with crystal violet (0.1% [wt/vol]) as described previously (25).
Isolation and characterization of BIMs. Bacteriophage-insensitive
mutants (BIMs) resistant to phages phiIPLA-RODI and phiIPLA-C1C
were obtained from strains S. aureus IPLA16 and S. epidermidis LO5081,
respectively. Aliquots of 100 l of overnight culture of each strain (108
CFU) were incubated with 100 l of phage (109 PFU) for 10 min at 37°C.
The mixture was then poured onto a 2% TSA plate and covered with 3 ml
of 0.7% TSA. Plates were incubated for 16 h at 37°C. Surviving colonies
were picked up and grown in fresh TSB medium for 16 h at 37°C. Bacte-
riophage susceptibility was tested by the drop assay (24). The BIM fre-
quency was calculated as the ratio between the number of surviving colo-
nies and the initial number of bacteria incubated in the presence of phage.
Surface hydrophobicity was determined according to the microbial
adhesion to solvents (MATS) assay, using hexadecane (Sigma-Aldrich,
Madrid, Spain) and stationary-phase cells washed with 0.15 M NaCl and
adjusted to a final OD600 of 0.8 (26). Eachmeasurement was performed in
triplicate, and the assay was carried out twice with independent cultures.
The susceptibilities of S. aureus IPLA16, S. epidermidis LO5081, and
their respective BIMs to several NaCl concentrations were evaluated by
determining the 50% lethal dose (LD50) values, defined as the concentra-
tion ofNaCl that inhibited the growth of the strain by 50% comparedwith
the control culture of the same strain growing in standard TSB (0.5%
NaCl). Overnight cultures were diluted to an OD600 of 0.05 in TSB con-
taining different NaCl concentrations (0.5 to 20%). Aliquots of 0.2 ml
were placed into 96-microwell plates (Nunclon D surface; Nunc, Rosk-
ilde,Denmark). Plateswere incubated at 37°C, and growthwasmonitored
in a Benchmark Plus microplate spectrophotometer (Bio-Rad Laborato-
ries) until the control samples reached an OD600 of 0.9  0.1. Growth
rates were estimated by linear regression after plotting the ln(OD600) as a
function of time during the exponential growth phase, as described pre-
viously (27). The adsorption kinetics and the adsorption rate constants (k)
of the phages were calculated as previously described (28).
Electronmicroscopy of phage particles. Electronmicroscopic exam-
ination was performed after negative staining of the phage particles with
2% uranyl acetate. Electron micrographs were taken using a JEOL 12.000
EXII transmission electron microscope (JEOL USA Inc., Peabody, MA).
DNA extraction and protein analysis.To prepare bacterial DNA-free
samples for sequence analysis, the purified phages were treated as de-
scribed previously (20). Analysis of virion proteins was carried out by
SDS-PAGE analysis and matrix-assisted laser desorption ionization–tan-
dem time of flight (MALDI-TOF/TOF) mass spectrometry as previously
described (29).
Bacteriophage genome analysis and characterization. The genome
sequences of phages phiIPLA-RODI and phiIPLA-C1C were determined
by GenProbio SRL (Parma, Italy), using an Ion Torrent personal genome
machine (PGM; Life Technologies). The MIRA program (version 3.4.0)
was used for assembly of genome sequences, resulting in 138-fold cover-
age for phiIPLA-C1C and 432-fold coverage for phiIPLA-RODI. Addi-
tional sequencing using specific primers was done to elucidate regions
with ambiguities. Phage genomes were autoannotated using RAST (30)
andweremanually curated. BLASTX and BLASTPwere used to search for
similar proteins (31). Structural predictions and motif searches were per-
formed with InterProScan (32). Putative promoters and Shine-Dalgarno
sites were predicted using the software MEME (33) followed by visual
inspection. ARNold (34) and TransTerm (35) were used to detect poten-
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tial rho-independent terminators. Putative tRNAs were predicted using
tRNAscan-SE (36) and ARAGORN (37). Genomic comparison at the nu-
cleotide level was made with EMBOSS Stretcher (38) and with MAUVE
(39), using the genome sequences available in public databases (July 2014)
for phages of the Myoviridae family infecting Staphylococcus. Before the
global alignments could be performed, the genomes weremanually colin-
earized, placing the arbitrary starting point at the end of the open reading
frame (ORF) preceding the large terminase subunit gene. The genome
organization of the phages and comparative BLASTN figures were gener-
ated using CGView server (40). Annotation was done on the basis of
homology with previously described phages.
Statistical analysis. Statistical analyses were performed to establish
any significant differences between the control and tested strains. The
differences are expressed as means  standard deviations for three bio-
logical replicates for all assays andwere determined by one-way analysis of
variance (ANOVA) followed by the Bonferroni multicomparison test. P
values of0.05 were considered statistically significant.
Nucleotide sequence accession numbers.The sequences of phiIPLA-
RODI and phiIPLA-C1C have been deposited in GenBank under acces-
sion numbers KP027446 and KP027447, respectively.
RESULTS
Bacteriophages phiIPLA-RODI and phiIPLA-C1C, two new
members of the Myoviridae family that infect staphylococcal
species. Two phages were isolated from sewage after enrichment
with four different mixtures of S. aureus strains. Frommixtures 1
and 4, two phages were further isolated, propagated, and purified,
using S. aureus IPLA1 as the host for phage phiIPLA-RODI and S.
epidermidis F12 for phage phiIPLA-C1C. The host ranges of the
isolated bacteriophages were determined by testing against a col-
lection of 47 bacterial strains (Table 1). Both phages showed a
wide host range, infecting 81% (phiIPLA-RODI) and 40%
(phiIPLA-C1C) of the Staphylococcus strains tested. For S. aureus,
all strainswere infected by phiIPLA-RODI,whereas phiIPLA-C1C
infected only three strains. All S. epidermidis strains were infected
by phiIPLA-C1C, indicating that phage phiIPLA-C1C is more
specific for S. epidermidis. In addition, 10 different species belong-
ing to the Staphylococcus genus were also sensitive to phiIPLA-
RODI, and 6 of themwere sensitive to phiIPLA-C1C. Both phages
were able to infect the Macrococcus caseolyticus IPLA101 strain
(Table 1).
Virions of both phages were observed by transmission electron
microscopy, and they showed isometric capsids and long contrac-
tile tails typical of theMyoviridae family (Fig. 1A). phiIPLA-RODI
has a capsid of 73 8 nm in diameter and a tail that is 95 8 nm
long. phiIPLA-C1C has a capsid of 88 10 nm in diameter and a
tail that is 110  13 nm long. A double baseplate upon tail con-
traction, which is typical of SPO1-related phages, was clearly ob-
served in both phages (41).
One-step growth curves under standardized conditions were de-
termined for both phages (Fig. 1B). The eclipse and latent periods of
phiIPLA-RODI on S. aureus IPLA16 and of phiIPLA-C1C on S.
epidermidis LO5081 were 15 and 20 min, respectively. The burst
sizes were estimated to be 25 and 15 phage particles per infected
cell for phiIPLA-RODI and phiIPLA-C1C, respectively (Fig. 1B).
Both phages appeared to be quite stable at temperatures below
60°C, but a total inactivation of the phages at temperatures over
70°C was observed (see Fig. S1 in the supplemental material).
Concerning pH stability, a notable reduction of 3.6 log units in the
phage titer was observed for phage phiIPLA-C1C at pH 11, while
phiIPLA-RODI was found to be quite stable at this pH. No viable
phages were recovered after incubation at pH 3 (see Fig. S1).
The genomic organization of phages phiIPLA-RODI and
phiIPLA-C1C is typical of the Spounaviridae subfamily.The ge-
FIG 1 (A) Transmission electron microphotographs of phages phiIPLA-RODI and phiIPLA-C1C. (B) One-step growth curves of phage phiIPLA-RODI in S.
aureus IPLA16 and phage phiIPLA-C1C in S. epidermidis LO5081. Values correspond to the numbers of PFU per infected cell in chloroform-treated cultures ()
and untreated cultures (). Each data point shows the mean standard deviation for three independent experiments.
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nomes of phiIPLA-RODI and phiIPLA-C1C are double-stranded
linear DNAmolecules of 142,348 bp (carrying 213 putativeORFs)
and 140,961 bp (carrying 203 putative ORFs), respectively, with
ORFs preceded by potential Shine-Dalgarno sequences (see Ta-
bles S1 and S2 in the supplemental material). Up to 40 and 27
putative promoters (see Table S3), respectively, were identified,
andmost of them showedAT-rich sequences upstreamof the35
region and corresponded to middle or early promoters. In addi-
tion, 52 and 33 putative rho-independent terminators were pre-
dicted for phiIPLA-RODI and phiIPLA-C1C, respectively (Table
S4). Twomain transcriptional units were identified in both phages
(Fig. 2 and 3).
Based on BLAST analysis and conserved domain screening,
putative functions have been assigned to 93 of the predicted ORFs
(44%) from phiIPLA-RODI and 80 of the predicted ORFs (39%)
from phiIPLA-C1C (see Tables S1 and S2, respectively). ORFs
were annotated based on the similarities of phiIPLA-RODI and
phiIPLA-C1C to phage K (accession number NC_005880) and S.
epidermidis phage phiIBB-SEP1 (accession number KF021268.1),
respectively.
Overall, genes of both phages are organized into four func-
tional modules, including genes for long terminal repeats (LTRs),
morphogenesis, cell lysis, and replication/transcription. Further-
more, the phiIPLA-RODI genome carries a tRNA gene between
orf18 and orf19, encoding tRNAMet, and three tRNA genes be-
tween orf59 and orf60, encoding tRNAAsp, tRNAPhe, and tRNATrp.
The presence of a conserved sequence (TGTCAAGTTAATTT)
was detected near these tRNA genes, at positions 8852 to 8865,
31999 to 32012, and 32179 to 32192, which may be binding sites
for a transcriptional regulatory factor (42). No tRNA genes were
identified in the phiIPLA-C1C genome.
The ends of the genomes of both phages are flanked by LTRs,
which are putatively involved in the recombination of phage ge-
nomes inside the cell. These regions encode small proteins impli-
cated in host takeover, redirecting cell metabolism to phage pro-
duction (43). The exact boundaries between these LTRs and the
rest of the genome have not been determined, but comparison
with the terminal repeat proteins of other phages suggests that
they may span from the TreA (orf192)- to the BofL (orf6)-encod-
ing genes in phiIPLA-RODI. In this fragment, genes encoding 28
putative terminal repeat proteins were detected. In addition to the
previously described TreA protein gene, the homologous TreB,
FIG 2 Genome organization of phage phiIPLA-RODI and BLASTN comparisons. The outer ring with arrows represents the ORFs of the circularized phage. The
predicted gene functions are also indicated. The different functional modules in the genome are shown by colored shading. BLASTn analysis, whose results are
represented by each inner ring, was performed with the representative phages Twort (dark red), K (green), and (most similar) GH15 (blue).
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TreC, TreE, TreF, TreJ, TreK, TreN, TreP, TreU, andTreT protein
genes were recognized in a region of 10,330 bp. In addition, the
gene for a putative group I homing HNH endonuclease (orf206),
which is typical of this region, was also identified. In phiIPLA-
C1C, LTRs could be expanded from the pentapeptide repeat
protein gene (orf143) to the BofL gene (orf165), with a total of
11,844 bp and genes encoding 23 putative proteins. In this
region, genes for three putative terminal repeat proteins, with
homology to TreK (orf150), TreO (orf152), and TreN (orf155),
were identified.
The morphogenesis module was split into two regions in both
genomes. In phiIPLA-RODI, these regions (orf67 to orf108 and
orf135 to orf139) were separated by the replication/transcription
module, whereas the LTR region and the replication/transcription
module were located between the two morphogenetic regions
(orf1 to orf42 and orf169 to orf171) in phiIPLA-C1C.Genes encod-
ing the large terminase subunit, portal protein, prohead protease,
major capsid, major tail sheath, and tape measure protein (TMP)
were identified. The large terminase subunit of phiIPLA-RODI
(orf67) presented a group I intron interspaced in the gene, while
this intronwas not present in phiIPLA-C1C (orf2). The remainder
of the proteins encoded in these regions failed to show similarity
to the terminase small subunits. The TMP-encoding gene is fol-
lowed by two putative genes in phiIPLA-RODI: orf95, which en-
codes a tail-associated protein withmuralytic activity (as deduced
from the presence of a CHAP domain); and orf96, which encodes
a protein with a predicted endopeptidase domain. Moreover, the
product of orf97 showed homology with glycerol-phosphodiester
hydrolytic activities. In phiIPLA-C1C, the TMP-encoding gene is
followed by four putative genes: orf28, encoding a glucosamini-
dase; orf29, encoding a lytic transglycosylase; orf30, encoding an
amidase with a CHAP domain; and orf31, encoding a peptidase.
The other genes in these modules are likely to encode baseplate,
structural, and assembly proteins. Protein analysis of viral parti-
cles allowed the identification of the adsorption-associated tail
protein (orf104), major tail sheath protein (orf85), capsid protein
(orf78), and major tail protein (orf136) in phage phiIPLA-RODI.
In phage phiIPLA-C1C, a tail protein (orf40), major tail sheath
(orf18), major capsid protein (orf11), and a hypothetical protein
(orf85) were also identified (Fig. 4).
The lysis modules, containing genes involved in bacterial lysis
(holin and endolysin), were located upstream of the morphoge-
netic module. In addition, putative transglycosylase-encoding
genes (orf53 in phiIPLA-RODI and orf174 in phiIPLA-C1C),
FIG 3 Genome organization of phage phiIPLA-C1C and BLASTN comparisons. The outer ring with arrows represents the ORFs of the circularized phage. The
predicted gene functions are indicated. The different functional modules in the genome are shown by colored shading. BLASTn analysis, whose results are
represented by each inner ring, was performed with the representative phages Twort (dark red), K (green), and (most similar) phiIBB-SEP1 (blue).
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whichmay be involved in cell wall hydrolysis, were also identified.
Moreover, in phiIPLA-C1C, a second holin gene (orf78) was lo-
cated downstream of the replication/transcription module.
In the replication and transcription module, several genes re-
lated to DNA replication (DNA helicase, DNA primase, resolvase,
DNA polymerase, and DNA repair protein), synthesis of DNA
precursors (ribonucleotide reductase), and gene regulation
(sigma factor and integration host factor) were identified. Addi-
tionally, two direct repeats of 41 nucleotides were found in the
phiIPLA-RODI genome, between orf60 and orf61 (AAAAAGTAC
GTATTTAGAAAATAAGGAACTCTCCTATTATA). These se-
quences share the 27 first nucleotides with a sequence of 28 nucle-
otides conserved in the Myoviridae family of phages infecting
Staphylococcus (except in phages Romulus, Remus, SA11, phiIBB-
SEP1, and Twort). These regions are supposed to be potential
binding sites for the replication initiator protein.
A group I intron associated with a VRS endonuclease was de-
tected in the middle of the terminase large subunit gene (orf68) in
phiIPLA-RODI, while in phiIPLA-C1C, two introns and one in-
tein were identified. The group I intron GIY-YIG homing endo-
nucleases were located interrupting the ribonucleotide reductase
large subunit (orf61) and DNA polymerase (orf69) genes. The in-
tein DOD homing endonuclease is encoded after the recombina-
tion protein (orf73). Additionally, in phiIPLA-C1C, two intron-
less ORFs encoding homing endonucleases (GIY-YIG and HNH)
were located in intergenic regions after orf171 and orf185, respec-
tively.
Comparative genomics. To perform comparative genomics,
genomes of Myoviridae phages infecting Staphylococcus were co-
linearized to start at the terminase large subunit. At the nucleotide
level, phage phiIPLA-C1C shares a similarity of 80.2% with the
only S. epidermidis-specific myophage, phiIBB-SEP1 (Table 2),
whereas its similarity with the S. aureus phages is55%, suggest-
ing that phiIPLA-C1C might be specific for S. epidermidis. Phage
phiIPLA-RODI is more closely related to the other phages in the
database (identities of over 80%), excluding phage phiIBB-SEP1
and the representative phage Twort, in which case the similarity is
56% (Table 2).
A MAUVE comparison allowed us to determine that all of
these phages possess the same general modular structure, includ-
ing the morphogenesis, replication/transcription, long terminal
repeat, and lysis modules. The morphogenesis and replication/
transcription modules are conserved among the Myoviridae
phages infecting Staphylococcus (Fig. 2 and 3; see Fig. S2 in the
supplemental material). The internal organization in these re-
gions is highly dependent on the presence of homing endonu-
cleases and transposases. Regarding the LTR region, phage
phiIPLA-RODI shared homology with all the phages except
Twort, phiIPLA-C1C, and phiIBB-SEP1. The phages phiIPLA-
C1C and phiIBB-SEP1 possess a specific organization in the LTR
region that is not shared with the other phages. The most vari-
able regions at the nucleotide level are located upstream of the
LTR region, in which differences regarding the length and gene
arrangement are found (see Fig. S2).
Killing of planktonic staphylococcal cultures by phiIPLA-
RODI and phiIPLA-C1C. Phages phiIPLA-RODI and phiIPLA-
C1C had the same lytic activity on S. aureus IPLA16, since no
viable bacteria were detected after 8 h of incubation and a consid-
erable decrease of the bacterial population was already achieved
after 6 h of treatment (7.9 log units compared to the control).Note
that both phages halted growth during the first 4 h, keeping bac-
terial counts at 105 CFU/ml (Fig. 5A). When S. epidermidis
LO5081 was infected by either phage, no viable counts were de-
FIG 4 Analysis by SDS-PAGE and silver staining of the structural proteins of
phages phiIPLA-RODI and phiIPLA-C1C. Protein molecular size markers
(kDa) are shown on the left (lane L). Bands marked with white arrowheads
were identified by mass spectrophotometry. The proteins in phage phiIPLA-
RODI were the adsorption-associated tail protein (orf104) (1), the major tail
sheath protein (orf85) (2), the capsid protein (orf78) (3), and the major tail
protein (orf136) (4). The proteins in phage phiIPLA-C1C were the tail protein
(orf40) (5), the major tail sheath (orf18) (6), the major capsid protein (orf11)
(7), and a hypothetical protein (orf85) (8).
TABLE 2 Comparative genomic analysis of Myoviridae phages infecting
Staphylococcus, using Emboss Stretcher
Phage
% similarity
phiIPLA-C1C phiIPLA-RODI
phiIPLA-C1C 100 54.8
phiIPLA-RODI 54.8 100
G1 54.6 83.5
GH15 54.2 84.3
JD007 54.1 83.5
K 53.6 81.1
Twort 53.4 54.5
vB_SauM_Remus 53.6 54.6
vB_SauM_Romulus 52.9 54.2
SA11 54.7 56.2
SA1 44.1 44.7
ISP 54.7 83.8
A5W 54.7 83.2
Sb-1 54.1 79
SA5 54.3 83.1
S25-3 55.1 81.2
S25-4 55.3 80.1
SA012 54.8 81.6
phiIBB-SEP1 80.2 55.8
P4W 55.1 83.6
MSA6 54.9 81.7
Fi200w 55 84.2
676Z 55 84.3
A3R 55.1 82.6
Staph1N 54.7 83.1
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tected after 8 h of incubation (Fig. 5B). However, phiIPLA-C1C
killed host cells more quickly than phiIPLA-RODI did, and after 4
h of incubation, only 10 CFU/ml viable cells remained. As ex-
pected, the number of phages increased in all infected cultures, to
about 109 PFU/ml (data not shown).
phiIPLA-RODI proved to be more effective than phiIPLA-
C1C for removal ofmono- and dual-species staphylococcal bio-
films. To perform challenge assays against mono- and dual-spe-
cies biofilms, an S. aureus IPLA16-derived strain that is resistant to
rifampin (S. aureus IPLA16-rifR) was isolated, with the same
phage sensitivity and biofilm formation as its parent (data not
shown). S. aureus IPLA16-rifR and S. epidermidis LO5081 were
grown in both mono- and dual-species biofilms and treated with
the phages individually and as a mixture. Numbers of surface-
adhered bacteria were successfully reduced after phage treatment
(Fig. 6A). In the presence of phiIPLA-RODI, a reduction of 2.43
log units was achieved for S. aureus IPLA16-rifR, with a reduction
of 1.89 log units for S. epidermidis LO5081. Phage phiIPLA-C1C
showed a reduced lytic ability against both staphylococcal bio-
films, with reductions in viable counts of 1.84 and 1.16 log units
for S. aureus IPLA16-rifR and S. epidermidis LO5081, respectively.
No significant reduction beyond that recorded for individual
phages was observed on biofilms treated with a mixture of phages
(Fig. 6A).
Planktonic cells of S. aureus IPLA16-rifR weremore sensitive to
lysis by phage phiIPLA-RODI (reduction of 4.27 log units) than
by phage phiIPLA-C1C (reduction of 0.76 log unit) (Fig. 6A).
However, neither individual phage nor the phage mixture was
able to kill planktonic S. epidermidisLO5081 (ANOVA;P 0.05)
(Fig. 6A).
In dual-species biofilms, treatment with phage phiIPLA-RODI
showed a reduction in adhered cells of 4.27 log units for S. aureus
IPLA16-rifR and of 2.66 log units for S. epidermidis LO5081 (Fig.
6B). Treatment of biofilms with phiIPLA-C1C was found to be
more effective than that observed in individual biofilms, with a
decrease in the adhered cells of 3.23 log units for S. aureus IPLA16-
rifR and 2.64 log units for S. epidermidis LO5081. Similar to the
monospecies biofilm challenge, the mixture of phages did not
clearly improve the results obtained by individual phages.
Regarding the planktonic cells, the efficacy of phiIPLA-RODI
was higher than that shown by phiIPLA-C1C against both strains
forming the dual-species biofilm (Fig. 6B). A reduction of 5.69 log
units in S. aureus IPLA16-rifR and of 0.64 log unit in S. epidermidis
LO5081 was obtained. For phiIPLA-C1C, only a weak reduction
in viable counts was detected for S. aureus IPLA16-rifR (Fig. 6B).
Treatment with a mixture of phages gave similar results to those
obtained using phiIPLA-RODI.
Crystal violet staining was used to confirm the reduction in the
total biomass of phage-treated biofilms (Fig. 6C). Overall, re-
moval of biomass by phage treatment in mono- and dual-species
biofilms was in accordance with the viable count results (see
above). However, in terms of total biomass, the phage treatment
turned out to bemore effective when amixture of both phages was
applied to both an S. epidermidis LO5081 single-species biofilm
and the dual-species biofilm (Fig. 6C). Similarly, the treatment
with phiIPLA-RODI was more effective than that with phiIPLA-
C1C. However, in biofilms formed only by S. aureus IPLA16-rifR,
all the treatments were found to have similar detachment abilities.
A phage resistance phenotype has an important fitness cost
and is highly unstable. BIMs of S. aureus IPLA16 after treatment
with phiIPLA-RODI (MOI 100) and of S. epidermidis LO5081
treatedwith phiIPLA-C1C (MOI 1,000) emerged at frequencies
of 4.05  107  2.34  109 and 1.1  107  2.08  109,
respectively. To test whether resistance implies fitness costs, three
phage-resistant colonies of S. aureus IPLA16 (S. aureus IPLA16-
R40, S. aureus IPLA16-R53, and S. aureus IPLA16-R71) and two
phage-resistant colonies of S. epidermidis LO5081 (S. epidermidis
LO5081-R49 and S. epidermidis LO5081-R32) were randomly se-
lected for further microbiological characterization (Table 3).
In phage-free liquid cultures, all the BIMs formed aggregates as
observed by optical microscopy (see Fig. S3 in the supplemental
material). Moreover, the growth rate of BIMs was clearly reduced
compared to that of wild-type strains (Table 3). Other parameters
indicative of cellular fitness, such as the ability of BIMs to grow in
high NaCl concentrations and to form biofilms on polystyrene
surfaces, were also determined. S. aureus IPLA16-derived BIMs
were sensitive to 8% NaCl (Table 3), whereas S. epidermidis
LO5081-derived BIMs showed resistance to NaCl similar to that
of control cultures. Phage-resistant bacteria of both species had a
reduced capacity to form biofilms on polystyrene surfaces (up to a
4-fold reduction for S. aureus IPLA16 BIMs and up to a 25-fold
reduction for S. epidermidis LO5081-R33), except for S. epidermi-
dis LO5081-R49, which showed values similar to those of thewild-
type strain (Table 3).
Regardless of the phage against which BIMs had arisen, they
were also resistant to either phiIPLA-RODI or phiIPLA-CIC as
well as to phages vB_SauS_phiIPLA88 (44) and vB_SepS_
phiIPLA5 (24), two Siphoviridae staphylococcal phages (data not
shown). Cross-resistance suggested that impaired phage infection
may have been due to a lower or nonexistent adsorption of phages.
The kinetics of phage binding indicated that adsorption of
phiIPLA-RODI and phiIPLA-C1C proceeded to 87 to 90% in 15
min for wild-type strains, while the adsorption rates of BIMs were
reduced to 38 to 62% in S. aureus and 23% in S. epidermidis BIMs
(Table 3), indicating that phage infection was prevented by low
adsorption of phages to the bacterial surface. Changes in cell sur-
face properties were further confirmed by the significantly less
hydrophobic character of the BIMs than of the wild-type strains
(Table 3).
To check whether the phage resistance phenotype of BIMs is
FIG 5 Susceptibilities of S. aureus IPLA16 (A) and S. epidermidis LO5081 (B)
to phages phiIPLA-RODI and phiIPLA-C1C. Cell counts of control cultures
() and cultures treated with phiIPLA-RODI (Œ) or phiIPLA-C1C () are
represented as log (CFU/ml). Each value corresponds to the mean standard
deviation for three independent experiments.
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stable without the selective pressure of phages, BIMs were subcul-
tured for 57 generations, and their sensitivities to phages phiIPLA-
RODI and phiIPLA-C1C were tested. S. aureus IPLA16-R40,
IPLA16-R53, and IPLA16-R71 showed a highly unstable pheno-
type, and sensitive cultures (a defined transparent halo was ob-
served) were obtained after 27 generations. More variability was
observed for S. epidermidis LO5081 BIMs, as S. epidermidis
LO5081-R49 reverted to the sensitive phenotype after 17 genera-
tions, while S. epidermidis LO5081-R33 lost phage resistance only
after 57 generations (Table 3). Recovery of phage sensitivity was
linked to the reestablishment of sensitivity to either phiIPLA-
RODI or phiIPLA-C1C and the two Siphoviridae phages. More-
over, the original growth rate was also restored (data not shown).
DISCUSSION
Within the bacteriophage therapy context, we have characterized
two new lytic phages, phiIPLA-RODI and phiIPLA-C1C, which
show the typical wide host range of polyvalent phages, such as
phage K and phi812 (45, 46), in contrast to other monovalent
myophages, such as Stau2, Romulus, and Remus (28, 47), whose
host range is limited to S. aureus strains, and phage phiIBB-SEP1,
infecting only S. epidermidis strains (48).
From the perspective of feasibility for therapeutic application,
we determined that the stabilities of phages phiIPLA-RODI and
phiIPLA-C1C at various pHs and temperatures were very similar
to those described for related phages, such as MSA6 (49) and
Romulus and Remus (28), and therefore that these phages are
suitable for design of different pharmaceutical formulations by
lyophilization (50), spray drying (51), and aerosolization (52).
Bioinformatic analysis of the phiIPLA-RODI and phiIPLA-C1C
genomes showed the typical characteristics of the “Twort-like vi-
ruses” (Spounavirinae subfamily): strictly virulent, with large ge-
nomes (127 to 140 kb) containing LTRs, genes grouped intomod-
ules that are not clearly separated, a few genes encoding tRNAs,
FIG 6 Bacteriophage-mediated removal of 24-h-old S. aureus and S. epidermidis biofilms. Mono (A)- or dual (B)-species biofilms of S. aureus IPLA16-rifR and
S. epidermidis LO5081 were treated with phage phiIPLA-RODI (dark gray), phage phiIPLA-C1C (light gray), or a mixture of both phages (white) for 4 h. Data
on control biofilms are presented in black. Adhered cell counts and supernatant cell counts are expressed as log (CFU/well). The bacterial detection thresholdwas
10 log (CFU/ml). (C) Alternatively, the biomass was calculated by crystal violet staining of adhered cells after phage treatment. The absorbance was measured at
a wavelength of 595 nm. Means and standard deviations were calculated for three biological replicates. Bars marked with an asterisk are significantly different
from the control (ANOVA; P 0.05), and bars marked with “a” indicate significantly different decreases in biomass between the treatment with the mixture of
phages and the individual treatment with either phiIPLA-RODI or phiIPLA-C1C (ANOVA; P 0.05).
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and the presence of group I introns (42). The genome of phage
phiIPLA-C1C differs from those of the above-mentioned phages
in the lack of genes encoding tRNAs, a peculiarity already ob-
served in the S. epidermidis phage phiIBB-SEP1 (48). In addition,
the nucleotide genome sequence of phiIPLA-RODI showed a lack
of restriction sites for the endonucleases Sau3AI, BamHI, and
BglII, but these are present in the phiIPLA-C1C genome. This
appears to be a general strategy among S. aureus bacteriophages,
such as Twort, K, G1, Sb-1, andMSA6, to avoid restriction by host
bacteria (49, 53).
Both phages encode homing endonucleases, found within
group I introns, intergenic regions, or inteins, in accordance
with previous results reported for other myophages, such as T4,
where 11% of the ORFs correspond to homing endonucleases
(54). In T4-related phages, most of the homing endonucleases
belong to the GIY-YIG and HNH families, with multiple func-
tions, such as recombination and binding to and repair of DNA
(54). Homing endonucleases encoded by phiIPLA-C1C were
not identified in other phage genomes, consistent with the idea
that these proteins are a recent evolutionary acquisition that
may have an influence on gene arrangement and function and
that, in addition, they may promote their own spread between
phages (54).
Once the phages were morphologically and genetically charac-
terized, we proceeded to study their lytic activity against staphy-
lococcal bacteria in both planktonic cultures and preformed bio-
films. The results of biofilm removal assays confirmed that phage
infection in planktonic cell cultures is more efficient than that in
biofilms. Overall, S. aureus IPLA16 biofilms were well infected by
both phages, while S. epidermidis LO5081 biofilms were found to
be more resistant to phage predation. A likely explanation is the
higher content of extracellular matrix formed by S. epidermidis
LO5081 than by S. aureus IPLA16, whichmay hinder the access of
phages to bacteria. Some phages encode polysaccharide depoly-
merase proteins which degrade the extracellular matrix of bio-
films, facilitating the access of phages to target bacteria (20). How-
ever, no genes encoding proteins with these catalytic domains
were detected in either the phiIPLA-RODI or phiIPLA-C1C ge-
nome. After biofilm treatment, it was also quite surprising that
detached cells were not killed by phages, except those released
from S. aureus IPLA16 biofilms treated with phiIPLA-RODI.
These data suggest that cells released from inside a biofilm are not
susceptible to phage infection due to their unique physiological
state (22). The biomass reductions of S. aureus IPLA16 biofilms by
these phages were similar (67% for phage phiIPLA-RODI and
69% for phage phiIPLA-C1C) to those obtained with phages ISP,
Romulus, and Remus (28). The complete eradication of biofilms
by phages has not been described in the literature to date. How-
ever, prevention of biofilm formation has been achieved for S.
aureusXen29 biofilms, using a combination of phage K andmod-
ified derivatives (21). In addition, S. aureusbiofilms could be erad-
icated efficiently with a combination of phage SAP-26 and rifam-
pin (55).
Phage control of dual-species biofilmswas investigated using S.
aureus and S. epidermidis as a proof of concept to evaluate whether
the mixture of both phages could be more effective than each
individual phage. Our results provide evidence that phages can
reduce the cell numbers of both species, but the application of a
phage mixture against each of the hosts was not always more ef-
fective than the use of only one phage. Indeed, the addition of the
single phage phiIPLA-RODI resulted in a reduction similar to that
achieved by the mixture of phages. The low efficacy of phiIPLA-
C1C may be due to the lower burst size of this phage than that of
phiIPLA-RODI. Overall, these results are in agreement with those
obtained by other authors (56, 57), who reported reductions of
about 3 to 4 log units in viable cells from mixed biofilms treated
with phages. Mixed-species biofilms are complex communities in
which the physiological state of cells and the availability of phage
receptors play important roles in the behavior of phages (58).
These features may be altered drastically by competition with
other bacterial species. In mixed cultures of Escherichia coli and
Salmonella, phages against E. coliwere more effective at removing
this species than in monocultures of E. coli. It seems that for some
bacteria, the competition with other bacterial species may en-
hance the effectiveness of phages, because phage bacterial resis-
tance can decrease the competitive ability of bacteria (59). Similar
TABLE 3 Fitness of S. aureus IPLA16 and S. epidermidis LO5081, and their BIMs, against phages phiIPLA-RODI and phiIPLA-C1C, respectivelya
Strain
Growth rate
() (h1)
LD50 of
NaCl (%)
Biofilm
formation
(OD595)
% phage
adsorption in
15 min
Adsorption rate constant (k)
(ml/min)
Hydrophobicity
(% adhesion to
hexadecane)
Generation
after which
reversion
occurred
S. aureus
IPLA16
0.76 0.02 8.14 0.42 1.13 0.06 87.67 3.74 8.9 1011 7.5 1012 85.62 5.47
S. aureus
IPLA16-R40
0.56 0.02* 6.12 0.33* 0.31 0.01* 62.66 2.09* 3.1 1010 7.1 1011* 44.47 7.67* 27
S. aureus
IPLA16-R53
0.59 0.04* 4.80 0.23* 0.28 0.02* 38.33 6.21* 6.5 1010 1.7 1011* 32.13 8.37* 27
S. aureus
IPLA16-R71
0.49 0.03* 2.82 0.34* 0.41 0.02* 39.66 3.25* 6.2 1010 1.2 1011* 34.77 8.17* 27
S. epidermidis
LO5081
0.74 0.03 8.23 0.74 9.81 0.38 90.60 8.19 6.5 1011 2.3 1012 95.43 2.06
S. epidermidis
LO5081-R32
0.58 0.02* 8.15 0.25 0.39 0.06* 17.60 7.23* 6.9 1010 1.3 1010* 33.78 6.65* 57
S. epidermidis
LO5081-R49
0.52 0.06* 8.13 0.08 8.99 0.47 23.00 5.69* 9.9 1010 1.7 1010* 77.05 11.31* 17
a Values represent the means standard deviations for three biological replicates. The presence of an asterisk indicates those values that are significantly different from those of the
wild-type strain (ANOVA; P 0.05).
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data were observed in our staphylococcal biofilms, in which treat-
ment with phages turned to be more effective in dual-species bio-
films than in monospecies biofilms.
Phage resistance is often a major concern in the therapeutic
application of phages, as it may compromise the efficacy of the
treatment (60). In this regard, the frequencies of bacteria acquir-
ing resistance to phages phiIPLA-RODI and phiIPLA-C1C were
determined to be low, and most important, the global fitness of
staphylococcal BIMs was clearly affected. This reduced fitness of
phage-resistant bacteria was also observed for different species,
such asVibrio cholerae (61) and Pseudomonas aeruginosa (62).We
have not determined the molecular basis of the phage resistance
mechanisms in the BIMs. However, it is known that wall teichoic
acid (WTA) serves as a receptor for several staphylococcal sipho-
viruses andmyoviruses (63). Therefore, a lack ofWTA in S. aureus
and S. epidermidis BIMs might explain the resistance of these
strains to phages belonging to the Siphoviridae and Myoviridae
families. In addition, phiIPLA-RODI and phiIPLA-C1C BIMs
were shown to be more sensitive to high temperatures, showed
higher degrees of cell aggregation, and had a reduced capacity to
form biofilms, as previously observed in S. aureus WTA-deficient
mutants (64). However, we cannot disregard the presence of a
capsular polysaccharide in staphylococcal BIMs, whichmaymod-
ify the bacterial surface properties and prevent phage adsorption
to the cell (65).
The data presented in this study support the potential of the
lytic bacteriophages phiIPLA-RODI and phiIPLA-C1C to be used
in phage therapy. Their characterization indicates a wide host
range, an adequate stability in various environmental conditions,
a lack of virulence factors, the capability to remove biofilms, and a
low frequency of BIMs.
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